REGNNASDAQ
Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock
Not HalalLast report: March 31, 2026
Shariah screening information
Screening summary
- Revenue
- Fail
- Debt
- Pass
- Securities and assets
- Pass
Financial ratios
- Debt ratio
- 3.15%
- Securities ratio
- 21.59%
- Non-halal and doubtful income ratio
- 5.47%
Revenue breakdown
- Halal revenue
- 94.53%
- Non-halal revenue
- 5.47%
- Doubtful revenue
- 0%
Financial breakdown
- Halal revenue
- 3.6b
- Non-halal revenue
- 208.5m
- Doubtful revenue
- 0
- Interest-bearing debt
- 2.7b
- Interest-bearing securities and assets
- 18.5k
- Total revenue
- 3.8b
- Trailing 36-month average market cap
- 85.9b
Screening information is provided for informational purposes and may change as securities are reviewed over time.
Frequently asked questions
Is Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock halal?
Screening status: Not Halal. Last report: March 31, 2026.